FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “DENASPOR”, which is offered here for Pharmaceutical for the treatment of organ transplant rejection, skin disorders and psoriasis, bone marrow transplant rejection, aplasic anemia, rheumatoid arthritis, and nephrotic syndrome;dena spor;.
Its status is currently believed to be active. Its class is unavailable. “DENASPOR” is believed to be currently owned by “DNA PHARMACEUTICALS, INC.”
| Owner: |
DNA PHARMACEUTICALS, INC.
Owner Details |
|---|---|
| Description: |
Pharmaceutical for the treatment of organ transplant rejection, skin disorders and psoriasis, bone marrow transplant rejection, aplasic anemia, Rheumatoid arthritis, and nephrotic syndrome;DENA SPOR;
|
| Categories: | PHARMACEUTICAL TREATMENT |